News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
McIntyre Gail Frances
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2022 |
4
| McIntyre Gail Frances (CEO and President) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 425,000 options to buy
@ $2.18, valued at
$926.5k
|
|
| 06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2021 |
4
| McIntyre Gail Frances (CEO and President) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 165,000 options
@ $5.95, valued at
$981.8k
|
|
| 12/07/2020 |
4
| McIntyre Gail Frances (CEO and President) has filed a Form 4 on Aravive, Inc.|
Txns:
| Bought 8,000 shares
@ $5.77, valued at
$46.2k
|
|
| 04/09/2020 |
4
| McIntyre Gail Frances (CEO and President) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 80,000 options
@ $6.16, valued at
$492.8k
|
|
| 01/24/2020 |
4
| McIntyre Gail Frances (Chief Scientific Officer) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 48,583 options
@ $10.84, valued at
$526.6k
|
|
| 03/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/07/2014 |
4
| McIntyre Gail Frances (Senior Vice President-Research) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 24,318 shares
@ $0
Disposed/sold 22,763 options to buy
@ $9.11, valued at
$207.4k
Disposed/sold 26,219 options to buy
@ $13.16, valued at
$345k
Disposed/sold 10,368 options to buy
@ $17.8, valued at
$184.6k
|
|
| 06/18/2014 |
4
| McIntyre Gail Frances (Senior Vice President-Research) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Sold 3,804 shares
@ $105, valued at
$399.4k
Sold 32,928 shares
@ $105, valued at
$3.5M
Sold 26,000 shares
@ $105.01, valued at
$2.7M
Sold 3,717 shares
@ $105.05, valued at
$390.5k
Sold 8,008 shares
@ $105, valued at
$840.8k
Exercised 32,928 options to buy
@ $9.11, valued at
$300k
Exercised 26,000 options to buy
@ $15, valued at
$390k
Exercised 3,717 options to buy
@ $13.16, valued at
$48.9k
Exercised 8,008 options to buy
@ $13.16, valued at
$105.4k
|
|
| 06/12/2014 |
4
| McIntyre Gail Frances (Senior Vice President-Research) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Sold 1,746 shares
@ $104.58, valued at
$182.6k
|
|
| 03/04/2014 |
4
| McIntyre Gail Frances (Senior Vice President-Research) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Granted 12,000 shares
@ $0 |
|
| 09/18/2013 |
4/A
| McIntyre Gail Frances (Senior Vice President-Research) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Sold 20,000 shares
@ $40, valued at
$800k
|
|
| 07/23/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/12/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/11/2012 |
4
| McIntyre Gail Frances (Senior Vice President-Research) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Granted 10,368 options to buy
@ $17.8, valued at
$184.6k
|
|
| 11/21/2011 |
4
| McIntyre Gail Frances (Senior Vice President-Research) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Bought 6,500 shares
@ $16.89, valued at
$109.8k
|
|
| 05/11/2011 |
4
| McIntyre Gail Frances (Senior Vice President-Research) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Granted 26,000 options to buy
@ $15, valued at
$390k
|
|
| 06/21/2010 |
4
| McIntyre Gail Frances (Senior Vice President-Research) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Granted 75,691 options to buy
@ $9.11, valued at
$689.5k
|
|
| 05/27/2010 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|